The U.S. Food and Drug Administration will organize meetings with independent group of experts to review data of coronavirus vaccine candidates and advice the agency, FDA commissioner Stephen Hahn said on Wednesday.
"The meetings will reinforce the transparency of the process as FDA reviews data from trials now underway," Hahn said in a post on Twitter.
The statement comes after U.S. President Donald Trump last month accused members, without evidence, of a so-called “deep state” working within the FDA of complicating efforts to test COVID-19 vaccines in order to delay results until after the Nov. 3 presidential election. The FDA last week said it will hold a meeting of its advisory committee to address the general development of COVID-19 vaccines on Oct. 22.
While several drugmakers including AstraZeneca Plc and Moderna Inc are conducting late-stage studies of their experimental coronavirus vaccines, there are no U.S.-approved vaccines for the novel coronavirus.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss COVID-19 Vaccines'The US_FDA announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on Oct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of [covid19 vaccines].'
Weiterlesen »
Doctors alarmed as FDA floats 'emergency use' of COVID-19 vaccine, bypassing trials“It’s a lesser review, it’s a lower-quality review, and when you’re talking about vaccinating a large chunk of the American population, that’s not acceptable,” said one vaccine expert.
Weiterlesen »
FDA head open to authorizing a COVID-19 vaccine before end of phase 3.DrJohnTorres on FDA willing to fast track COVID-19 vaccine before phase 3 trials end: 'The concern is that they are kind of jumpstarting it a little bit ... that's what has a lot of experts concerned.'
Weiterlesen »
FDA says outside pressure won't influence COVID-19 vaccine approvalThe commissioner said, depending on that data, it&39;s possible a vaccine could be available by Election Day and before a Phase III trial is completely finished.
Weiterlesen »
What Changing Death Rates Tell Us About COVID-19'The bottom line is simple: COVID-19 is a scary disease that kills a lot of the people that it infects.' Experts break down what changing death rates tell us about COVID-19:
Weiterlesen »
Large trials for anticipated Oxford COVID-19 vaccine begin in the U.S.Despite pressure from the White House, researchers may not be able to say whether the vaccine works until after the election.
Weiterlesen »